AGP Picks
View all

Today's News: Middle East
Provided by AGP

Today's News: Middle East: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today's News: Middle East.

September 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30

October 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

November 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30

Press releases published on November 12, 2026

GoldHaven Identifies New High-Grade Tungsten Mineralization at Magno Project, Returning 8,850 PPM Tungsten
Nov. 12, 2026

GoldHaven Identifies New High-Grade Tungsten Mineralization at Magno Project, Returning 8,850 PPM Tungsten

Indeterminate GlobeNewswire
Sol-Gel Reports Third Quarter 2026 Financial Results and Provides Corporate Updates
Nov. 12, 2026

Sol-Gel Reports Third Quarter 2026 Financial Results and Provides Corporate Updates

Indeterminate GlobeNewswire
Foresight Successfully Completes Integration into Modular Autonomous Ground Vehicles for Defense Applications
Nov. 12, 2026

Foresight Successfully Completes Integration into Modular Autonomous Ground Vehicles for Defense Applications

Indeterminate GlobeNewswire
CollPlant to Begin Trading on Nasdaq Under New Ticker Symbol “OPHI”
Nov. 12, 2026

CollPlant to Begin Trading on Nasdaq Under New Ticker Symbol “OPHI”

Indeterminate GlobeNewswire
Avalyn Reports Third Quarter 2026 Financial Results and Recent Business Highlights
Nov. 12, 2026

Avalyn Reports Third Quarter 2026 Financial Results and Recent Business Highlights

Indeterminate GlobeNewswire
Kyverna Therapeutics Announces Completion of BLA Submission for Miv-cel in Stiff Person Syndrome and Reports Third Quarter 2026 Financial Results
Nov. 12, 2026

Kyverna Therapeutics Announces Completion of BLA Submission for Miv-cel in Stiff Person Syndrome and Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire
NevGold Intercepts Strongest Result To Date in 2026: 8.28 g/t Oxide Au Over 3.0 Meters Within 1.73 g/t Oxide Au Over 45.7 Meters
Nov. 12, 2026

NevGold Intercepts Strongest Result To Date in 2026: 8.28 g/t Oxide Au Over 3.0 Meters Within 1.73 g/t Oxide Au Over 45.7 Meters

Indeterminate GlobeNewswire
SAFO AI Investment S.L. Supports El Jardinet dels Gats in Barcelona, Building Community Ties During YESTA Development
Nov. 12, 2026

SAFO AI Investment S.L. Supports El Jardinet dels Gats in Barcelona, Building Community Ties During YESTA Development

Indeterminate EIN Presswire
Nexxen Reports Record Third Quarter 2026 Financial Results
Nov. 12, 2026

Nexxen Reports Record Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire
Biolojic Design Receives U.S. FDA Clearance of Investigational New Drug (IND) Application for BD200, the First Multibody to Enter Clinical Trials
Nov. 12, 2026

Biolojic Design Receives U.S. FDA Clearance of Investigational New Drug (IND) Application for BD200, the First Multibody to Enter Clinical Trials

Indeterminate GlobeNewswire
Altimmune Announces Third Quarter 2026 Financial Results and Business Update
Nov. 12, 2026

Altimmune Announces Third Quarter 2026 Financial Results and Business Update

Indeterminate GlobeNewswire
TSX Opening and Chibougamau Project Update
Nov. 12, 2026

TSX Opening and Chibougamau Project Update

Indeterminate GlobeNewswire
Ouverture des marchés de la TSX et mise à jour sur le projet Chibougamau
Nov. 12, 2026

Ouverture des marchés de la TSX et mise à jour sur le projet Chibougamau

Indeterminate GlobeNewswire
Avicanna Reports Positive Adjusted EBITDA for Q3 2026 and Provides Corporate Update
Nov. 12, 2026

Avicanna Reports Positive Adjusted EBITDA for Q3 2026 and Provides Corporate Update

Indeterminate GlobeNewswire
Cormedix Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
Nov. 12, 2026

Cormedix Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire
Altimmune Announces Publication of IMPACT Phase 2b 48-Week Data in MASH in The Lancet Gastroenterology & Hepatology
Nov. 12, 2026

Altimmune Announces Publication of IMPACT Phase 2b 48-Week Data in MASH in The Lancet Gastroenterology & Hepatology

Indeterminate GlobeNewswire
NervGen Receives FDA Breakthrough Therapy Designation for NVG-291 in Chronic Spinal Cord Injury
Nov. 12, 2026

NervGen Receives FDA Breakthrough Therapy Designation for NVG-291 in Chronic Spinal Cord Injury

Indeterminate GlobeNewswire
San Lorenzo Gold Provides Drilling Update at Cerro Blanco and Advances San Juan Exploration
Nov. 12, 2026

San Lorenzo Gold Provides Drilling Update at Cerro Blanco and Advances San Juan Exploration

Indeterminate GlobeNewswire
Az Aleph vállalattal kötött kizárólagos viszonteladói megállapodás révén az OpenAI 44 országban bővíti a ChatGPT-hirdetések elérhetőségét
Nov. 12, 2026

Az Aleph vállalattal kötött kizárólagos viszonteladói megállapodás révén az OpenAI 44 országban bővíti a ChatGPT-hirdetések elérhetőségét

Indeterminate GlobeNewswire
Century Therapeutics Reports Third Quarter 2026 Financial Results and Business Updates
Nov. 12, 2026

Century Therapeutics Reports Third Quarter 2026 Financial Results and Business Updates

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Today's News: Middle East

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.